Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 28.20
+2.27 (8.75%)
Nov 3, 2025, 2:45 PM CST
SHE:000766 Revenue
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of 242.27M CNY in the quarter ending September 30, 2025, a decrease of -24.15%. This brings the company's revenue in the last twelve months to 1.25B, down -10.84% year-over-year. In the year 2024, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had annual revenue of 1.32B, down -10.23%.
Revenue (ttm)
1.25B
Revenue Growth
-10.84%
P/S Ratio
21.79
Revenue / Employee
813.46K
Employees
1,532
Market Cap
27.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.32B | -150.79M | -10.23% |
| Dec 31, 2023 | 1.47B | 2.60M | 0.18% |
| Jan 1, 2023 | 1.47B | -44.73M | -2.95% |
| Jan 1, 2022 | 1.52B | 403.68M | 36.31% |
| Dec 31, 2020 | 1.11B | -865.40M | -43.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |